Vanda Pharmaceuticals | 应收帐款人





应收帐款人 更改 日
Acadia Pharmaceuticals USD 139.44M 19.75M 2025-09
Agios Pharmaceuticals USD 5.03M 43K 2025-09
Akebia Therapeutics USD 61.54M 27.17M 2025-03
Alnylam Pharmaceuticals USD 964.77M 397.66M 2025-09
Anika Therapeutics USD 21.99M 1.61M 2025-03
Arrowhead Research USD 218.87M 212.05M 2025-12
AstraZeneca USD 17.56B 1.32B 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Esperion Therapeutics USD 60.36M 5.75M 2024-06
Halozyme Therapeutics USD 346.04M 29.7M 2025-09
Heron Therapeutics USD 67.04M 6.9M 2024-09
Insmed USD 65.26M 10.23M 2025-09
J&J USD 17.61B 235M 2025-09
Lexicon Pharmaceuticals USD 2.62M 1.09M 2024-06
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
Merck USD 12.12B 596M 2025-09
Moderna USD 1.05B 589M 2025-09
Novartis USD 8.98B 192M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 203.07M 6.94M 2025-09
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 100M 2025-12
Takeda JPY 757.92B 55.68B 2025-12
Teva Pharmaceutical Industries USD 3.71B 101M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Veracyte USD 47.83M 2.99M 2025-09


Vanda Pharmaceuticals 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.